Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
12/2005
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/08/2005CA2565486A1 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005CA2565066A1 Therapeutic compounds
12/07/2005EP1601656A1 Tetrahydroquinoline derivatives useful as serine protease inhibitors
12/07/2005EP1601358A1 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005CN1705730A Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/06/2005CA2325282C Use of apo b secretion/mtp inhibitors
12/06/2005CA2163115C N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005WO2005113513A2 Aryl sulfonamides
12/01/2005WO2005113510A1 Dpp-iv inhibitors
12/01/2005WO2005080313A3 Sulfonamide derivatives for the treatment of diseases
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267146 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005CA2567854A1 Dpp-iv inhibitors
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists
11/2005
11/30/2005EP1259485B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/30/2005EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110991A1 1-aryl-4-substituted isoquinolines
11/24/2005US20050261346 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261334 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
11/24/2005US20050261326 Metabolites of ecteinascidin 743
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2564517A1 1-aryl-4-substituted isoquinolines
11/24/2005CA2564489A1 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
11/23/2005EP1598341A1 DPP-IV inhibitors
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108367A1 Compounds for treatment of neurodegenerative diseases
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050257295 Production of reticuline
11/17/2005US20050256211 Patient oxygenation using stabilized fluorocarbon emulsions
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005EP1594845A2 Benzene acetamide compounds useful as serine protease inhibitors
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP0981517B1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105760A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005WO2005105746A1 Organometallic complex, luminous solid, organic el element and organic el display
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005082858A3 Isoquinoline derivatives
11/10/2005US20050250949 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same
11/10/2005US20050250896 Compositions for producing aminoplast products and method for producing products from these compositions
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592689A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP0975353B1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/08/2005US6962996 Inhibitors of p38
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245522 Novel compounds
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245507 7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1690049A Process for preparing (s)-6, 7-dimethoxy-1, 2, 3, 4-tetrahydro isoquinoline-3-carboxylic acid
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
10/2005
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005US20050239797 Isoquinoline and quinazoline derivatives having a combined 5HT1A, 5HT1B, and 5HT1D receptor activity
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587516A1 Amide and ester matrix metalloproteinase inhibitors
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958205 Image forming material and ammonium compound
10/25/2005CA2331053C Compositions and methods for treating conditions responsive to estrogen
10/20/2005WO2005097750A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 119